Rhabdomyosarcoma: all 242 studies
Page 2 of 3. Open to participants first (49), then studies with results posted, then the rest; newest registration first within each.
- AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00659360Phase 2Results posted
- Proton Radiation Therapy (RT) for the Treatment of Pediatric RhabdomyosarcomaCompletedNCT00592592Not applicableResults posted
- A Study of Pemetrexed in Children With Recurrent CancerCompletedNCT00520936Phase 2Results posted
- Trial of Dasatinib in Advanced SarcomasCompletedNCT00464620Phase 2Results posted
- Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantCompletedNCT00408681Not applicableResults posted
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaCompletedNCT00354835Phase 3Results posted
- High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or EctomesenchymomaCompletedNCT00354744Phase 3Results posted
- Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell TransplantCompletedNCT00309907Phase 2Results posted
- Radiation Therapy to Treat Musculoskeletal TumorsActive, not recruitingNCT00186992Phase 2Results posted
- Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaCompletedNCT00112463Phase 2Results posted
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk RhabdomyosarcomaCompletedNCT00075582Phase 3Results posted
- Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of TumorsCompletedNCT00070109Phase 2Results posted
- A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric SarcomasCompletedNCT00001566Phase 2Results posted
- Radiological Diagnosis of Pediatric Neck SwellingsActive, not recruitingNCT07734805
- Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large ModelsCompletedNCT06822842
- Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult ParticipantsTerminatedNCT06566092Phase 1
- A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerActive, not recruitingNCT06521567Phase 1/2
- Retrospective Study in FFPE Samples From Younger Patients With RhabdomyosarcomaCompletedNCT06040229
- Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in ChildrenStatus unknownNCT05708391Phase 2
- PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineCompletedNCT05697198
- Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid TumorsTerminatedNCT05429502Phase 1
- Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid TumorsCompletedNCT05302921Phase 2
- A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
- Phase 2 Study of 9-ING-41 With Chemotherapy in SarcomaWithdrawnNCT05116800Phase 2
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid TumorsActive, not recruitingNCT05103631Phase 1
- 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsNo longer availableNCT05064306
- A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk RhabdomyosarcomaActive, not recruitingNCT04994132Phase 3
- Drug Sensitivity and Mutation ProfilingCompletedNCT04956198
- A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasWithdrawnNCT04906876Phase 2
- Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid TumorsSuspendedNCT04890093Phase 1/2
- Indo-cyanine Green (ICG) in Paediatric Oncology MISCompletedNCT04854018Phase 4
- A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid TumorsWithdrawnNCT04791228Phase 2
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT04483778Phase 1
- Evolutionary Therapy for RhabdomyosarcomaActive, not recruitingNCT04388839Phase 2
- Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsActive, not recruitingNCT04337177Phase 1
- Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent RhabdomyosarcomaActive, not recruitingNCT04299113Phase 1
- Heated Intra-peritoneal Chemotherapy with Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTerminatedNCT04213794Early Phase 1
- A Study of the Drugs Prexasertib, Irinotecan, and Temozolomide in People With Desmoplastic Small Round Cell Tumor and RhabdomyosarcomaCompletedNCT04095221Phase 1/2
- Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
- Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue SarcomasStatus unknownNCT03989596Phase 2
- Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in ChildrenStatus unknownNCT03868852Phase 1/2
- Ex Vivo Drug Sensitivity Testing and Mutation ProfilingCompletedNCT03860376
- Impact of an Orthotic Intervention in Children With Peripheral NeuropathyCompletedNCT03655587Not applicable
- Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallStatus unknownNCT03651375Phase 2
- C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Active, not recruitingNCT03635632Phase 1
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 1
- Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)Active, not recruitingNCT03496402Not applicable
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 1
- Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old PatientsActive, not recruitingNCT03462888
- Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in ChildrenWithdrawnNCT03111069Phase 1
- Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryCompletedNCT03009201Phase 1
- Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid TumorsCompletedNCT02982941Phase 1
- Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803CompletedNCT02890758Phase 1
- A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory MedulloblastomaCompletedNCT02748135Phase 1
- Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWithdrawnNCT02689336Phase 2
- Abemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsCompletedNCT02644460Phase 1
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid TumorsWithdrawnNCT02557854Phase 1
- A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid TumorsTerminatedNCT02536183Phase 1
- Trabectedin and Irinotecan for Refractory Pediatric SarcomasStatus unknownNCT02509234
- Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue SarcomasCompletedNCT02415816Not applicable
- Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for SarcomasStatus unknownNCT02409576Phase 1/2
- Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsCompletedNCT02390843Phase 1
- TAA-Specific CTLS for Solid Tumors (TACTASOM)CompletedNCT02239861Phase 1
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsCompletedNCT02076906Phase 1
- Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid TumorsWithdrawnNCT02011126Phase 2
- Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified ChemotherapyActive, not recruitingNCT01871766Phase 2
- Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or RhabdoomyosarcomaCompletedNCT01858168Phase 1
- Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid TumorsStatus unknownNCT01807468Phase 2
- A Study of LY2940680 in Pediatric Medulloblastoma or RhabdomyosarcomaWithdrawnNCT01697514Phase 1
- Effects of Preoperative Physical Therapy in Patients With Lower Extremity MalignancyCompletedNCT01674101Not applicable
- Biomarkers in Patients With Advanced RhabdomyosarcomaCompletedNCT01668095
- Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsCompletedNCT01661400Phase 1
- Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With RhabdomyosarcomaCompletedNCT01626170
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
- Studying Protein Expression in Tissue Samples From Younger Patients With RhabdomyosarcomaCompletedNCT01609803
- PK/PD of XM22 in Children With Ewing Family of Tumors or RhabdomyosarcomaCompletedNCT01585649Phase 1
- Studying Genes in Samples From Younger Patients With RhabdomyosarcomaCompletedNCT01585376
- CREATE: Cross-tumoral Phase 2 With CrizotinibCompletedNCT01524926Phase 2
- Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid TumorsCompletedNCT01518413Phase 1
- Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable
- Biomarkers in Tumor Tissue Samples From Younger Patients With RhabdomyosarcomaCompletedNCT01496573
- Biomarkers in Patients With RhabdomyosarcomaCompletedNCT01466283
- Studying Biomarkers in Samples From Patients With RhabdomyosarcomaCompletedNCT01433237
- Protein Expression in Samples From Young Patients With RhabdomyosarcomaCompletedNCT01426945
- DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With RhabdomyosarcomaCompletedNCT01419509
- NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT01386619Phase 1/2
- Biomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaCompletedNCT01365962
- Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed RhabdomyosarcomaCompletedNCT01355445Phase 2
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and SarcomaCompletedNCT01241162Phase 1
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue SarcomasStatus unknownNCT01216839Phase 2
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsCompletedNCT01169584Phase 1
- Markers of Anthracycline-Related Cardiac Muscle InjuryWithdrawnNCT01112800
- Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesCompletedNCT01048892Phase 1
- A Vaccine Study for High Risk CancersWithdrawnNCT00944580Phase 1
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsCompletedNCT00931931Phase 1
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue SarcomaCompletedNCT00919269
- Collecting and Storing Tissue From Young Patients With CancerCompletedNCT00898755
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442